ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
November 25 2024 - 4:15PM
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage
oncology company focused on developing treatments that address
mechanisms of therapeutic resistance, today announced that
management will participate in the following investor conferences
in December:
-
7th Annual Evercore
HEALTHCONx Conference – Participating in a fireside chat
on Wednesday, December 4, 2024, at 2:35 p.m. ET
- Citi’s
2024 Global Healthcare Conference – Participating in the
“Novel Mechanisms in Oncology II” panel on Thursday, December 5,
2024, at 11:00 a.m. ET
Live webcasts of the discussions will be
available through the investor section of the company’s website at
www.oricpharma.com. Replays of the webcasts will be available for
90 days following the events.
About ORIC Pharmaceuticals,
Inc. ORIC Pharmaceuticals is a clinical stage
biopharmaceutical company dedicated to improving patients’ lives
by Overcoming Resistance In Cancer. ORIC’s
clinical stage product candidates include (1) ORIC-114, a brain
penetrant inhibitor that selectively targets EGFR exon 20, HER2
exon 20 and EGFR atypical mutations, being developed across
multiple genetically defined cancers, (2) ORIC-944, an allosteric
inhibitor of the polycomb repressive complex 2 (PRC2) via the EED
subunit, being developed for prostate cancer, and (3) ORIC-533, an
orally bioavailable small molecule inhibitor of CD73, a key node in
the adenosine pathway believed to play a central role in resistance
to chemotherapy- and immunotherapy-based treatment regimens, being
developed for multiple myeloma. Beyond these three product
candidates, ORIC® is also developing multiple precision medicines
targeting other hallmark cancer resistance mechanisms. ORIC has
offices in South San Francisco and San Diego, California. For more
information, please go to www.oricpharma.com, and follow us
on X or LinkedIn.
Contact:Dominic Piscitelli,
Chief Financial
Officerdominic.piscitelli@oricpharma.cominfo@oricpharma.com
Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Nov 2024 to Dec 2024
Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Dec 2023 to Dec 2024